Dr. Berg's Ozempic 'natural alternatives' claim fact-checked

What did @drbergofficial actually say?

Dr. Berg claims that Ozempic works by increasing a receptor called GLP-1, which slows digestion, reduces appetite, and leads to weight loss. He also says it improves beta cells in the pancreas, restores insulin levels, reduces insulin resistance, and has liver effects including reducing gluconeogenesis and slowing sugar breakdown.

The core pitch in the caption is that "natural alternatives" exist that produce the same results without side effects. The short video is essentially a mechanism explainer used as a funnel to his website. That framing matters, because it shapes how loosely he handles the science.

To be fair, the mechanism description he gives is not fabricated. Most of what he says tracks with established pharmacology. But there are some notable imprecisions that matter clinically, and the "no side effects" claim in the caption is flatly unsupported.

Does the science back this up?

Mostly, yes, with important caveats. Semaglutide is a GLP-1 receptor agonist, meaning it binds to and activates GLP-1 receptors rather than simply "increasing" them. That is a meaningful pharmacological distinction. The appetite suppression, gastric emptying delay, and glycemic benefits are well-documented.

The liver effects he describes are real. GLP-1 receptor agonists have been shown to reduce hepatic glucose output, partly through suppression of glucagon and partly through direct hepatic signaling. A 2021 meta-analysis by Zhu et al. in Diabetes Care confirmed reductions in fasting glucose and HbA1c that are consistent with reduced gluconeogenesis. The beta cell claim is also supported: research published by Peyot et al. and others has shown semaglutide has cytoprotective effects on pancreatic beta cells in animal models, though human data on functional beta cell restoration is more limited and ongoing.

Insulin resistance improvement is well-established in the clinical trial record, including the SUSTAIN and STEP trial programs, and is partly a downstream effect of weight loss itself.

What did they get wrong (or right)?

The biggest error is in the mechanism framing. Berg says Ozempic "increases a certain receptor called GLP-1." That is imprecise in a way that misleads viewers. GLP-1 is a hormone, not a receptor. The receptor is the GLP-1 receptor. Ozempic activates it, it does not increase it or the hormone. A small distinction? Not really, because it affects how people understand why natural GLP-1 boosters would or would not work similarly.

He also says it "helps restore insulin levels," which is vague to the point of being misleading. Semaglutide stimulates glucose-dependent insulin secretion. It does not restore baseline insulin production in a clinically durable way independent of continued drug use. The beta cell preservation data in humans is promising but not conclusive enough to call it restoration.

What he gets right: the appetite suppression mechanism, the gastric emptying effect, the gluconeogenesis point, and the insulin resistance connection are all directionally accurate. Credit where it is due.

What is not addressed but should be: the caption's claim of "no side effects" for natural alternatives is unsupported and irresponsible. GLP-1 receptor agonists have a well-documented side effect profile including nausea, vomiting, and pancreatitis risk. Any alternative claiming equivalent benefit with zero side effects needs evidence, not marketing copy.

What should you actually know?

Semaglutide's mechanisms are genuinely multi-pathway. It is not just an appetite suppressant. The hepatic and pancreatic effects are real and are part of why it performs better than older diabetes drugs in cardiovascular outcome trials, including the SUSTAIN-6 trial published in the New England Journal of Medicine (Marso et al., 2016).

The phrase "natural alternatives" does a lot of heavy lifting with very little evidence behind it. Berberine, for example, is frequently cited in this space. It does have some GLP-1 pathway activity in limited studies, but no head-to-head trial shows equivalency to semaglutide for weight loss or glycemic control. Claiming no side effects ignores berberine's own GI side effect profile and drug interaction potential.

If you are considering GLP-1 therapy, the mechanism Dr. Berg describes is real. But the implicit suggestion that you can replicate it with supplements and skip the side effects is not supported by clinical evidence. Talk to a licensed provider who can review your full history before making any changes.